A5085574208- Multiple Myeloma Research and Treatments
- Intraperitoneal and Appendiceal Malignancies
- Chemokine receptors and signaling
- Cytokine Signaling Pathways and Interactions
- Ovarian cancer diagnosis and treatment
- Renal Transplantation Outcomes and Treatments
- Cancer Mechanisms and Therapy
- Sarcoma Diagnosis and Treatment
- Hematological disorders and diagnostics
- Renal cell carcinoma treatment
CRUK Lung Cancer Centre of Excellence
2024
University College London
2022-2023
Cancer Research UK
2023
MRC Clinical Trials Unit at UCL
2022
Standard-of-care first-line chemotherapy for epithelial ovarian cancer is carboplatin and paclitaxel administered once every 3 weeks. The JGOG 3016 trial reported significant improvement in progression-free overall survival with dose-dense weekly 3-weekly (ie, weeks) carboplatin. However, this benefit was not observed the previously results of ICON8. Here, we present final coprimary outcomes updated analyses